R&D Systems™ Recombinant Human BAI3 Protein

Catalog No.	Quantity
91-06B-A050	50 μg

Catalog No. 91-06B-A050 Supplier R&D Systems™ Supplier No. 9106BA050

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The Recombinant Human BAI3 Protein is derived from HEK293. The Recombinant Human BAI3 Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: NP_001695
• For Use With (Application): Bioactivity
• Gene ID (Entrez): 577
• Molecular Weight (g/mol): Observed M.W.: 109-132kDa, reducing conditions, Theoretical M.W.: 97kDa
• Quantity: 50 μg
• Source: Human embryonic kidney cell,HEK293-derived human BAI3 protein Ala25-Thr880,with C-terminal 6-His tag
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU per 1μg of the protein by the LAL method.
• Gene Alias: brain-specific angiogenesis inhibitor 3, dJ91B17.1 (brain-specific angiogenesis inhibitor 3), KIAA0550MGC133100
• Common Name: BAI3
• Gene Symbol: BAI3
• Biological Activity: Measured by its binding ability in a functional ELISA. When Recombinant Human C1qL3 is immobilized at 1μg/mL, 100μL/well, the concentration of Recombinant Human BAI3 that produces 50% of the optimal binding response is approximately 0.3-1.8μg/mL.
• Conjugate: Unconjugated
• Species: Human
• Recombinant: Recombinant
• Expression System: Human embryonic kidney cell, HEK293-derived Ala25-Thr880, with C-terminal 6-His tag
• Purity or Quality Grade: >90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining